Pharmaceutical giant Eli Lilly and Co. agreed December 20 to pay $29.4 million to settle charges by the U.S. Securities and Exchange Commission that it violated the Foreign Corrupt Practices Act by making improper payments to officials in Russia, Brazil, China and Poland.
Eli Lilly Settles SEC Case Involving Bribery Violations
The National Law Journal
December 24, 2012
This article requires premium access
This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.